Form 4: Coeptis Therapeutics Holdings Director Reports Stock Transac
Insider Transaction (Form 4)
Kenneth Lyle Cooper, a Director of Coeptis Therapeutics Holdings, Inc., reported multiple transactions in common stock on May 27, 2026.
Summary
- Option exercise/conversion: acquired 274 Common Stock on May 27, 2026; holds 274 after (Direct).
- Option exercise/conversion: acquired 274 Common Stock on June 27, 2026; holds 548 after (Direct).
- Option exercise/conversion: acquired 274 Common Stock on July 27, 2026; holds 822 after (Direct).
- Option exercise/conversion: acquired 274 Common Stock on August 27, 2026; holds 1,096 after (Direct).
- Option exercise/conversion: acquired 274 Common Stock on September 27, 2026; holds 1,370 after (Direct).
- Option exercise/conversion: disposed of 274 Restricted Stock Units on May 27, 2026; holds 9,594 after (Direct).
- Option exercise/conversion: disposed of 274 Restricted Stock Units on June 27, 2026; holds 9,320 after (Direct).
- Option exercise/conversion: disposed of 274 Restricted Stock Units on July 27, 2026; holds 9,046 after (Direct).
- Option exercise/conversion: disposed of 274 Restricted Stock Units on August 27, 2026; holds 8,772 after (Direct).
- Option exercise/conversion: disposed of 274 Restricted Stock Units on September 27, 2026; holds 8,498 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kenneth Lyle Cooper — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-05-27 | Option exercise/conversion | Common Stock | 274 | — | — | 274 |
| 2026-06-27 | Option exercise/conversion | Common Stock | 274 | — | — | 548 |
| 2026-07-27 | Option exercise/conversion | Common Stock | 274 | — | — | 822 |
| 2026-08-27 | Option exercise/conversion | Common Stock | 274 | — | — | 1,096 |
| 2026-09-27 | Option exercise/conversion | Common Stock | 274 | — | — | 1,370 |
| 2026-05-27 | Option exercise/conversion | Restricted Stock Units | 274 | — | — | 9,594 |
| 2026-06-27 | Option exercise/conversion | Restricted Stock Units | 274 | — | — | 9,320 |
| 2026-07-27 | Option exercise/conversion | Restricted Stock Units | 274 | — | — | 9,046 |
| 2026-08-27 | Option exercise/conversion | Restricted Stock Units | 274 | — | — | 8,772 |
| 2026-09-27 | Option exercise/conversion | Restricted Stock Units | 274 | — | — | 8,498 |
Key Dates
| Date | Description |
|---|---|
| 2026-05-27 | Option exercise/conversion (274 shares) |
| 2026-06-27 | Option exercise/conversion (274 shares) |
| 2026-07-27 | Option exercise/conversion (274 shares) |
| 2026-08-27 | Option exercise/conversion (274 shares) |
| 2026-09-27 | Option exercise/conversion (274 shares) |
| 2026-05-27 | Option exercise/conversion (274 shares) |
| 2026-06-27 | Option exercise/conversion (274 shares) |
| 2026-07-27 | Option exercise/conversion (274 shares) |
| 2026-08-27 | Option exercise/conversion (274 shares) |
| 2026-09-27 | Option exercise/conversion (274 shares) |
Keywords
insider transaction, Form 4, ZSQR, Z Squared Inc., neutral, Kenneth Lyle Cooper
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.